CTD-T AM 12.5/40/5 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Chlorthalidone (12.5mg)
Overview CTD-T AM 12.5/40/5 Tablet
The combined medication CTD-T AM 12.5/40/5 Tablet is prescribed for hypertension management when monotherapy proves insufficient. Its action lowers elevated blood pressure, mitigating the risk of future cardiovascular events like stroke and heart attack. Administer this tablet with food, adhering to a consistent daily schedule as directed by your physician. Dosage is individualized, contingent on your response and overall health. Continuous use, as per your doctor's instructions, is vital; discontinuation may increase stroke or heart attack risk. This medication includes a diuretic, increasing urination; therefore, avoid taking it within four hours of bedtime. Regular intake, even during periods of well-being, maximizes therapeutic effects. Hypertension often presents asymptomatically. Common side effects encompass ankle swelling, headache, dizziness, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counter potential side effects such as dry mouth, thirst, and muscle weakness. Prior to commencing treatment, inform your doctor of any pre-existing kidney or liver conditions, pregnancy, or breastfeeding. Comprehensive disclosure of all concurrent medications, especially those for cardiovascular issues or hypertension, is crucial. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is essential to optimize treatment efficacy and safety.
Uses of CTD-T AM 12.5/40/5 Tablet
Elevated blood pressure
Major Benefits of CTD-T AM 12.5/40/5 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the CTD-T AM 12.5/40/5 Tablet with a meal.
Common Side effects of CTD-T AM 12.5/40/5 Tablet:
- Headache
- Dizziness
- Sleepiness
- Edema (swelling)
- Increased uric acid level in blood
- Fatigue
- Increased blood lipid level
- Increased liver enzymes
- Visual disturbance
- Breathlessness
- Muscle cramp
- Gastrointestinal disturbance
- Electrolyte imbalance
- Increased glucose level in blood
- Urticaria
- Postural hypotension (low blood pressure)
- Impotence
How to use CTD-T AM 12.5/40/5 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the CTD-T AM 12.5/40/5 Tablet with a meal.
How CTD-T AM 12.5/40/5 Tablet works:
The tablet CTD-T AM 12.5/40/5 combines telmisartan, amlodipine, and chlorthalidone to manage hypertension. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, act synergistically to vasodilate, thus reducing blood pressure. Chlorthalidone, a diuretic, promotes diuresis, eliminating excess fluid and electrolytes, and contributes to vasodilation and improved circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside CTD-T AM 12.5/40/5 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Use of CTD-T AM 12.5/40/5 tablets is contraindicated during pregnancy due to confirmed fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The use of CTD-T AM 12.5/40/5 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with CTD-T AM 12.5/40/5 Tablets. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and safe driving.
KidneyCAUTION
Exercise caution when administering CTD-T AM 12.5/40/5 Tablet to individuals with severely impaired renal function. Dosage modification may be necessary. Physician consultation is advised. This medication is generally unsuitable for patients with such conditions.
LiverCAUTION
Individuals with liver impairment should use CTD-T AM 12.5/40/5 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. The use of CTD-T AM 12.5/40/5 Tablets is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take CTD-T AM 12.5/40/5 Tablet :
Should you forget a CTD-T AM 12.5/40/5 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CTD-T AM 12.5/40/5 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |






